Please provide your email address to receive an email when new articles are posted on . Among IOLs for presbyopia, trifocal options are gaining increasing appreciation. According to many users, ...
Please provide your email address to receive an email when new articles are posted on . The FineVision HP trifocal IOL was approved in October 2025. Five leading surgeons conducted the initial ...
FINEVISION HP is the first patented diffractive trifocal IOL and is one of the flagship products in BVI’s IOL portfolio; FINE Trifocal technology is utilized across the company’s entire range of ...
Milestone strengthens the company’s leadership in advanced IOL innovation FINEVISION HP, with millions of implantations worldwide, will now be available to U.S. patients Proprietary design features ...
A discussion of his situation led to the selection of the enVista Envy IOL. One month postoperatively, the patient achieved ...
WALTHAM, Mass., Oct. 14, 2025 (GLOBE NEWSWIRE) -- BVI, a global leader in ophthalmic device innovation, today announced that the U.S. Food and Drug Administration (FDA) has approved its FINEVISION HP ...